GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 17 May 2024.Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals declined 72.22% to Rs 45.72 crore in the quarter ended December 2023 as against Rs 164.56 crore during the previous quarter ended December 2022. Sales rose 0.37% to Rs 805.26 crore in the quarter ended December 2023 as against Rs 802.30 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales805.26802.30 0 OPM %27.0828.51 - PBDT245.85252.03 -2 PBT228.74235.62 -3 NP45.72164.56 -72 Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals rose 12.45% to Rs 217.51 crore in the quarter ended September 2023 as against Rs 193.42 crore during the previous quarter ended September 2022. Sales rose 4.38% to Rs 956.99 crore in the quarter ended September 2023 as against Rs 916.87 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales956.99916.87 4 OPM %30.2528.02 - PBDT317.27278.51 14 PBT299.16262.15 14 NP217.51193.42 12 Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2023.Powered by Capital Market - Live News